RNF2 and ovarian carcinoma: Interestingly, higher expression of RNF2 induces cisplatin resistance in ovarian cancers, and its knockdown enhanced the radiosensitivity of lung cancer cell lines, suggesting its role in promoting tumorigenesis (46, 47).